A case of disseminated cryptococcosis caused by Cryptococcus neoformans var. grubii is presented in a male diabetic who had AIDS. The diagnosis was based upon the isolation and identification of the aetiological agent from a lymph-node biopsy, cerebrospinal fluid and sputum. The isolate formed spherical, encapsulated yeast cells, produced cherry-brown colonies on niger-seed agar, grew on canavanine-glycine-bromothymol blue (CGB) medium, changing its colour from greenish yellow to blue, and hydrolysed urea weakly in the presence of 100 μM EDTA. The strain was unable to assimilate d-proline and, serologically, it was untypable. The identity of the isolate as C. neoformans var. grubii, serotype A, possessing a mating-type allele Aα, was confirmed by crossing with standard laboratory test strains and by performing PCR with the mating-type α allele-specific primer of the STE12 gene and with serotype (A and D)- and mating type (a and α)-specific primers of the STE20 gene. To the best of our knowledge, this is the first report of disseminated cryptococcosis in an AIDS patient caused by a canavanine-resistant strain of C. neoformans var. grubii, serotype A, possessing mating type allele Aα; the strain is probably a hybrid. The report suggests that, in the absence of a clear-cut serotyping result, a positive CGB reaction alone is not sufficient for intervarietal discrimination and additional confirmatory evidence is required.
ChaturvediS,
RodeghierB,
FanJ,
McClellandC. M,
WickesB. L,
ChaturvediV.2000; Direct PCR of Cryptococcus neoformans MAT α and MAT a pheromones to determine mating type, ploidy, and variety: a tool for epidemiological and molecular pathogenesis studies. J Clin Microbiol 38:2007–2009
CroweS. M,
CarlinJ. B,
StewartK. L,
LucasC. R,
HoyJ. F.1991; Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 4:770–776
FranzotS. P,
SalkinI. F,
CasadevallA.1999; Cryptococcus neoformans var. grubii : separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 37:838–840
HallidayC. L,
BuiT,
KrockenbergerM,
MalikR,
EllisD. H,
CarterD. A.1999; Presence of α and a mating types in environmental and clinical collections of Cryptococcus neoformans var. gattii strains from Australia. J Clin Microbiol 37:2920–2926
Kwon-ChungK. J,
WickesB. L,
BoothJ. L,
VishniacH. S,
BennettJ. E.1987; Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans . Infect Immun 55:1751–1754
MinK. H,
Kwon-ChungK. J.1986; The biochemical basis for the distinction between the two Cryptococcus neoformans varieties with CGB medium. Zentbl Bakteriol Mikrobiol Hyg A 261:471–480
MitchellT. G,
PerfectJ. R.1995; Cryptococcosis in the era of AIDS – 100 years after the discovery of Cryptococcus neoformans . Clin Microbiol Rev 8:515–548
NakamuraY,
KanoR,
SatoH,
WatanabeS,
TakahashiH,
HasegawaA.1998; Isolates of Cryptococcus neoformans serotype A and D developed on canavanine-glycine-bromthymol blue medium. Mycoses 41:35–40[CrossRef]
NCCLS1997Reference method for broth dilution susceptibility testing for yeasts Approved Standard M27-A Wayne, PA: National Committee for Clinical Laboratory Standards;
NishikawaM. M,
Sant'AnnaO. D,
LazeraM. S,
WankeB.1996; Use of d-proline assimilation and CGB medium for screening Brazilian Cryptococcus neoformans isolates. J Med Vet Mycol 34:365–366[CrossRef]
SaagM. S,
GraybillR. J,
LarsenR. A,
PappasP. G,
PerfectJ. R,
PowderlyW. G,
SobelJ. D,
DismukesW. E.2000; Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. . Clin Infect Dis 30:710–718[CrossRef]
SugarA. M,
HitchcockC. A,
TrokeP. F,
PicardM.1995; Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B. Antimicrob Agents Chemother 39:598–601[CrossRef]
SukroongreungS,
NilakulC,
RuangsomboonO,
ChuakulW,
EampokalapB.1996; Serotypes of Cryptococcus neoformans isolated from patients prior to and during the AIDS era in Thailand. Mycopathologia 135:75–78[CrossRef]
van der HorstC. M,
SaagM. S,
CloudG. A.9 other authors1997; Treatment of cryptococcal meningitis associated with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med 337:15–21
YanZ,
LiX,
XuJ.2002; Geographic distribution of mating type alleles of Cryptococcus neoformans in four areas of the United States. J Clin Microbiol 40:965–972